Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38728) 38728
Publication (1732) 1732
Book / eBook (484) 484
Newspaper Article (462) 462
Newsletter (187) 187
Book Review (159) 159
Book Chapter (84) 84
Magazine Article (82) 82
Conference Proceeding (78) 78
Web Resource (40) 40
Report (34) 34
Government Document (13) 13
Journal / eJournal (12) 12
Trade Publication Article (12) 12
Paper (11) 11
Dissertation (10) 10
Data Set (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30837) 30837
male (17154) 17154
female (16373) 16373
middle aged (11890) 11890
adult (9877) 9877
animals (9160) 9160
aged (9100) 9100
iodine radioisotopes - therapeutic use (8789) 8789
index medicus (8519) 8519
radiology, nuclear medicine & medical imaging (6216) 6216
radiotherapy dosage (5463) 5463
radioisotopes (5428) 5428
oncology (5346) 5346
cancer (4157) 4157
mice (3942) 3942
radiotherapy (3842) 3842
radionuclide imaging (3779) 3779
brachytherapy (3666) 3666
iodine radioisotopes (3606) 3606
treatment outcome (3569) 3569
therapy (3194) 3194
follow-up studies (3141) 3141
brachytherapy - methods (3054) 3054
radioisotopes - therapeutic use (3021) 3021
time factors (3003) 3003
rats (2956) 2956
adolescent (2704) 2704
cobalt radioisotopes - therapeutic use (2700) 2700
nuclear medicine (2668) 2668
aged, 80 and over (2646) 2646
combined modality therapy (2601) 2601
retrospective studies (2592) 2592
tissue distribution (2321) 2321
thyroid neoplasms - radiotherapy (2207) 2207
pharmacology & pharmacy (2063) 2063
radiology (2057) 2057
carbon radioisotopes (2036) 2036
isotopes (2026) 2026
radioisotope teletherapy (2018) 2018
radiopharmaceuticals - therapeutic use (2006) 2006
prognosis (1975) 1975
care and treatment (1951) 1951
child (1903) 1903
patients (1868) 1868
carcinoma (1863) 1863
radiology and nuclear medicine (1856) 1856
medicine (1837) 1837
medicine & public health (1836) 1836
radioisotope brachytherapy (1823) 1823
dosimetry (1764) 1764
tumors (1754) 1754
prostatic neoplasms - radiotherapy (1741) 1741
yttrium radioisotopes - therapeutic use (1668) 1668
radiopharmaceuticals (1657) 1657
thyroidectomy (1632) 1632
diseases (1625) 1625
surgery (1621) 1621
radiation therapy (1571) 1571
endocrinology & metabolism (1546) 1546
radioimmunotherapy (1475) 1475
tomography, x-ray computed (1434) 1434
diagnosis (1426) 1426
organs (1403) 1403
body (1402) 1402
nuclei (1397) 1397
neoplasm staging (1387) 1387
antibodies, monoclonal - therapeutic use (1385) 1385
positron-emission tomography (1363) 1363
neoplasms (1353) 1353
beta decay radioisotopes (1348) 1348
iodine radioisotopes - adverse effects (1264) 1264
thyroid neoplasms - pathology (1262) 1262
prostate cancer (1255) 1255
radiation (1228) 1228
radiation dosage (1222) 1222
dose-response relationship, radiation (1187) 1187
methods (1186) 1186
cell line, tumor (1170) 1170
positron emission tomography (1163) 1163
prospective studies (1158) 1158
research (1154) 1154
iridium radioisotopes - therapeutic use (1149) 1149
thyroid neoplasms - surgery (1144) 1144
antineoplastic agents - therapeutic use (1143) 1143
chemotherapy (1143) 1143
health aspects (1136) 1136
analysis (1113) 1113
mice, nude (1111) 1111
pet (1107) 1107
radiopharmaceuticals - pharmacokinetics (1062) 1062
irradiation (1045) 1045
kinetics (1043) 1043
brachytherapy - adverse effects (1040) 1040
survival rate (1039) 1039
imaging / radiology (1035) 1035
positron-emission tomography - methods (1032) 1032
neoplasms - radiotherapy (1028) 1028
iodine (999) 999
intermediate mass nuclei (984) 984
hematology, oncology and palliative medicine (981) 981
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (316) 316
Online Resources - Online (41) 41
Collection Dvlpm't (Acquisitions) - Closed Orders (13) 13
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
UTL at Downsview - May be requested (9) 9
Gerstein Science - Periodical Stacks (7) 7
Gerstein Science - Bindery (6) 6
UofT at Mississauga - Stacks (6) 6
UofT at Scarborough - Stacks (5) 5
Physics - Stacks (4) 4
Engineering & Comp. Sci. - Stacks (3) 3
Gerstein Science - Circulation Desk (3) 3
Robarts - Stacks (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Physics - Storage (2) 2
Aerospace - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Missing (1) 1
Physics - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34619) 34619
German (1909) 1909
French (885) 885
Russian (650) 650
Japanese (466) 466
Italian (368) 368
Spanish (334) 334
Polish (274) 274
Chinese (272) 272
Czech (75) 75
Portuguese (73) 73
Dutch (61) 61
Hungarian (59) 59
Danish (40) 40
Romanian (27) 27
Swedish (26) 26
Croatian (22) 22
Hebrew (19) 19
Finnish (14) 14
Bulgarian (13) 13
Serbian (12) 12
Ukrainian (11) 11
Norwegian (10) 10
Slovak (9) 9
Turkish (5) 5
Korean (3) 3
Lithuanian (3) 3
Afrikaans (2) 2
Arabic (2) 2
Greek (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Therapeutic use of artificial radioisotopes
by Hahn, Paul Francis, 1908
1956, 414
Radioisotopes | Therapeutic use
Book
Details down arrow
2. Cancer biotherapy & radiopharmaceuticals
Cancer biotherapy & radiopharmaceuticals, ISSN 1557-8852, 1996
Chemotherapy
Journal
Details down arrow
3. Clinical use of radioisotopes [by] William H. Beierwaltes, Philip C. Johnson [and] Arthur J. Solari
by Beierwaltes, William H. 1916-2005 (William Henry) and Johnson, Philip C and Solari, Arthur J
1957, 456
Radioisotopes | Therapeutic use
Book
Details down arrow
4. Radionuclides in therapy
by Seevers, Robert H and Friedman, Arnold M and Spencer, Richard Paul
1987, ISBN 9780849358432, 201
Radioisotopes | Therapeutic use
Book
Details down arrow
5. Therapeutic use of fluorinated nucleosides - progress in patents
by Bassetto, Marcella and Slusarczyk, Magdalena
Pharmaceutical patent analyst, 11/2018, Volume 7, Issue 6, pp. 277 - 299
Fluorinated nucleosides constitute a large class of chemotherapeutics approved for clinical use. The pharmacokinetic and pharmacodynamic properties of a drug... 
Fluorinated-nucleosides | phosph(on)ate prodrugs | F-PET tracers | antiviral | nucleophilic fluorination | N-glycosylation | anticancer
Journal Article
Details down arrow
6. Manual on the use of radioisotopes in hospitals
American Hospital Association
1958, Its [Publication] M39-58, 44
Radioisotopes | Radiotherapy | Therapeutic use
Book
Details down arrow
7. Full Text Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer
by Vignani, Francesca and Bertaglia, Valentina and Buttigliero, Consuelo and Tucci, Marcello and Scagliotti, Giorgio V and Di Maio, Massimo
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 61 - 73
Highlights • The interplay between tumor and bone microenvironment plays a crucial role in metastatic CRPC. • Bone metastases from CRPC are associated with... 
Hematology, Oncology and Palliative Medicine | Bone-targeted therapy | Bone metastasis | Chemotherapy | Skeletal related event | Castration resistant prostate cancer | New generation hormonal agents | SOLID TUMORS | RANDOMIZED-TRIAL | ZOLEDRONIC ACID | MITOXANTRONE PLUS PREDNISONE | ONCOLOGY | DOUBLE-BLIND | ABIRATERONE ACETATE | THERAPEUTIC TARGETS | QUALITY-OF-LIFE | PLACEBO-CONTROLLED TRIAL | ORAL SODIUM CLODRONATE | Anilides - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - pathology | Denosumab - therapeutic use | Taxoids - therapeutic use | Diphosphonates - therapeutic use | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Mitoxantrone - therapeutic use | Carcinoma - secondary | Pyridines - therapeutic use | Carcinoma - drug therapy | Radioisotopes - therapeutic use | Dasatinib - therapeutic use | Docetaxel | Androstenes - therapeutic use | Bone Density Conservation Agents - therapeutic use | Zoledronic Acid | Prostatic Neoplasms, Castration-Resistant - drug therapy | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Care and treatment | Metastasis | Prostate cancer | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Les isotopes radioactifs en médecine
by Visscher, Michel de and Beckers, C
1961, Volume 3., 166
Radioisotopes | Radiology, Medical | Therapeutic use
Book
Details down arrow
9. European journal of nuclear medicine and molecular imaging
European Association of Nuclear Medicine
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 2001
Radioisotopes | Diagnostic Imaging | Nuclear Medicine | Diagnostic Techniques, Radioisotope | therapeutic use
Journal
Details down arrow
10. Full Text US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun
by D'Amico, Anthony V and D'Amico, Anthony V
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 4, pp. 362 - 364
ONCOLOGY | Phenylthiohydantoin - therapeutic use | United States | Humans | Drugs, Investigational | Male | Antineoplastic Agents - therapeutic use | Drug Approval | Androstenols - therapeutic use | Oligopeptides - therapeutic use | Taxoids - therapeutic use | Diphosphonates - therapeutic use | Imidazoles - therapeutic use | Goserelin - therapeutic use | Mitoxantrone - therapeutic use | Prostatic Neoplasms - drug therapy | United States Food and Drug Administration | Antibodies, Monoclonal, Humanized - therapeutic use | Radioisotopes - therapeutic use | Docetaxel | Androstenes | Tissue Extracts - therapeutic use | Zoledronic Acid | Denosumab | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Estramustine - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
by Dik J Kwekkeboom and Boen L Kam and Martijn van Essen and Jaap J M Teunissen and Casper H J van Eijck and Roelf Valkema and Marion de Jong and Wouter W de Herder and Eric P Krenning
Endocrine-Related Cancer, ISSN 1351-0088, 03/2010, Volume 17, Issue 1, pp. R53 - R73
Somatostatin receptor imaging (SRI) with [ 111 In-DTPA 0 ]octreotide has proven its role in the diagnosis and staging of gastroenteropancreatic neuroendocrine... 
LUNG-CANCER | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY-GROUP | ISLET-CELL CARCINOMA | ONCOLOGY | PHASE-I TRIAL | RADIONUCLIDE THERAPY | ENDOCRINOLOGY & METABOLISM | LOW-GRADE | MEDULLARY-THYROID CARCINOMA | QUALITY-OF-LIFE | OCTREOTIDE SCINTIGRAPHY | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Quality of Life | Indium Radioisotopes - therapeutic use | Somatostatin - therapeutic use | Radiopharmaceuticals - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Immunotherapy of cancer in 2012
by Kirkwood, John M and Butterfield, Lisa H and Tarhini, Ahmad A and Zarour, Hassane and Kalinski, Pawel and Ferrone, Soldano
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 09/2012, Volume 62, Issue 5, pp. 309 - 335
The immunotherapy of cancer has made significant strides in the past few years due to improved understanding of the underlying principles of tumor biology and... 
PHASE-III TRIAL | TUMOR-INFILTRATING LYMPHOCYTES | HIGH-RISK MELANOMA | ANTI-CD40 MONOCLONAL-ANTIBODY | METASTATIC MALIGNANT-MELANOMA | PULSED DENDRITIC CELLS | COLONY-STIMULATING FACTOR | ONCOLOGY | HEPATOCELLULAR-CARCINOMA PATIENTS | CD8(+) T-CELLS | RECOMBINANT INTERLEUKIN-2 THERAPY | Immunotherapy - methods | Dendritic Cells - immunology | Humans | Dendritic Cells - physiology | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Immunotherapy - trends | Angiogenesis Inhibitors - therapeutic use | Receptor, ErbB-2 - antagonists & inhibitors | Cetuximab | Yttrium Radioisotopes - therapeutic use | Gene Transfer Techniques | Histocompatibility Antigens - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Vaccines, DNA - therapeutic use | alpha-Fetoproteins - therapeutic use | alpha-Fetoproteins - immunology | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Genetic Vectors | Trastuzumab | Care and treatment | Usage | Research | Health aspects | Immunotherapy | Cancer | Immunology | Cancer therapies | Manipulation | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies
by Crawford, E. David and Higano, Celestia S and Shore, Neal D and Hussain, Maha and Petrylak, Daniel P
Journal of Urology, The, ISSN 0022-5347, 2015, Volume 194, Issue 6, pp. 1537 - 1547
Purpose The availability of newly approved treatment options for metastatic castration resistant prostate cancer is not matched with conclusive data on optimal... 
Urology | neoplasm metastasis | androgen antagonists | drug therapy | castration | prostatic neoplasms | MANAGEMENT | DOCETAXEL | PROGNOSTIC MODEL | PREDNISONE | CABAZITAXEL | MEN | UROLOGY & NEPHROLOGY | ABIRATERONE ACETATE | INCREASED SURVIVAL | CLINICAL ACTIVITY | ENZALUTAMIDE | Phenylthiohydantoin - adverse effects | Phenylthiohydantoin - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - pathology | Taxoids - therapeutic use | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Prostatic Neoplasms, Castration-Resistant - therapy | Taxoids - adverse effects | Radioisotopes - therapeutic use | Androstenes - adverse effects | Radioisotopes - adverse effects | Docetaxel | Tissue Extracts - adverse effects | Androstenes - therapeutic use | Survival Rate | Radium - adverse effects | Tissue Extracts - therapeutic use | Radium - therapeutic use | Disease Progression | Phenylthiohydantoin - analogs & derivatives | Orchiectomy | Taxoids - administration & dosage | Neoplasm Metastasis - pathology | Androgen Antagonists - therapeutic use | Prostatic Neoplasms, Castration-Resistant - mortality | Androgen Antagonists - adverse effects | Neoplasm Staging | Medical colleges | Care and treatment | Metastasis | Prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights